Advertisement

CRISPR

In an interview with “EWTN News Nightly” anchor Tracy Sabol, National Catholics Bioethics Center President Dr. Joseph Meaney discusses the first-ever therapy approved by the FDA using CRISPR, a genome editing technology. | Credit: “EWTN News Nightly”

"Groundbreaking" Gene-editing Therapy Receives Thumbs up from Catholic Bioethicist

Dec 12, 2023

A new gene-editing therapy designed to help treat patients suffering from sickle cell disease has been endorsed by the National Catholic Bioethics Center.